F2-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome

Biochimie

Volumn 95, Issue 1, 2013, Pages 86-90

  Durand, Thierry ^a   De Felice, Claudio ^b   Signorini, Cinzia ^c   Oger, Camille ^a   Bultel Poncé, Valérie ^a   Guy, Alexandre ^a   Galano, Jean Marie ^a   Leoncini, Silvia ^c   Ciccoli, Lucia ^c   Pecorelli, Alessandra ^c   Valacchi, Giuseppe ^d,e   Hayek, Joussef ^b  

^a CNRS   (France)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e Kyung Hee University   (South Korea)

Author keywords

Adrenic acid; Autism spectrum disorders; Biomarkers; F2 Dihomo isoprostanes; MeCP2; Myelin damage; Oxidative damage; Total synthesis

Indexed keywords

ABC TRANSPORTER; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; F2 DIHOMO ISOPROSTANE; ISOPROSTANE DERIVATIVE; METHYL CPG BINDING PROTEIN 2; MYELIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADRENOLEUKODYSTROPHY; DISEASE COURSE; DISEASE MARKER; ELECTROSPRAY MASS SPECTROMETRY; GENE MUTATION; HORNER WADSWORTH EMMONS REACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; OXIDATIVE STRESS; PHENOTYPE; REFERENCE VALUE; RETT SYNDROME; REVIEW; TANDEM MASS SPECTROMETRY; WHITE MATTER INJURY;

BIOLOGICAL MARKERS; BRAIN; ERUCIC ACIDS; F2-ISOPROSTANES; HUMANS; LEUKOENCEPHALOPATHIES; LIPID PEROXIDATION; METHYL-CPG-BINDING PROTEIN 2; MYELIN SHEATH; OXIDATIVE STRESS; RETT SYNDROME;

EID: 84870567078     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.09.017     Document Type: Review

References (28)

1. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutation in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet. 23 1999 185 188
2. P.S. Sastry Lipids of nervous tissue: composition and metabolism Prog. Lipid Res. 24 1985 69 176
3. 2-Dihomo-isoprostanes arise from free radical attack on adrenic acid J. Lipid Res. 49 2008 995 1005
4. 2-Dihomo- isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome J. Lipid Res. 52 2011 2287 2297
5. C. Oger, Y. Brinkmann, S. Bouazzaoui, T. Durand, and J.-M. Galano Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework Org. Lett. 10 2008 5087 5090
6. C. Oger, S. Marton, Y. Brinkmann, V. Bultel-Poncé, T. Durand, M. Grabber, and J.M. Galano Lipase-catalyzed regioselective monoacetylation of unsymmetrical 1,5-primary diols J. Org. Chem. 75 2010 1892 1897
7. 2t-Isoprostanes J. Org. Chem. 75 2010 2411 2414
8. C. Oger, V. Bultel-Poncé, A. Guy, T. Durand, and J.-M. Galano Total syntheses of isoprostanes derived from AdA and EPA Eur. J. Org. Chem. 2012 2621 2634
9. J.L. Neul, W.E. Kaufmann, D.G. Glaze, J. Christodoulou, A.J. Clarke, N. Bahi-Buisson, H. Leonard, M.E. Bailey, N.C. Schanen, M. Zappella, A. Renieri, P. Huppke, A.K. Percy RettSearch Consortium Rett syndrome: revised diagnostic criteria and nomenclature Ann. Neurol. 68 2010 944 950
10. S.M. Weng, F. McLeod, M.E. Bailey, and S.R. Cobb Synaptic plasticity deficits in an experimental model of Rett syndrome: long term potentiation saturation and its pharmacological reversal Neuroscience 180 2011 314 321
11. C. De Felice, L. Ciccoli, S. Leoncini, C. Signorini, M. Rossi, L. Vannuccini, G. Guazzi, G. Latini, M. Comporti, G. Valacchi, and J. Hayek Systemic oxidative stress in classic Rett syndrome Free Radic. Biol. Med. 47 2009 440 448
12. S. Leoncini, C. De Felice, C. Signorini, A. Pecorelli, T. Durand, G. Valacchi, L. Ciccoli, and J. Hayek Oxidative stress in Rett syndrome: natural history, genotype, and variants Redox Rep. 16 2011 145 153
13. C. Signorini, C. De Felice, S. Leoncini, A. Giardini, M. D'Esposito, S. Filosa, F. Della Ragione, M. Rossi, A. Pecorelli, G. Valacchi, L. Ciccoli, and J. Hayek F4-neuroprostanes mediate neurological severity in Rett syndrome Clin. Chim. Acta 412 2011 1399 1406
14. J. Pan, J. Lane, H. Hetherington, and A. Percy Rett syndrome: 1H spectroscopic imaging at 4.1 T J. Child Neurol. 14 1999 524 528
15. M. Cappa, C. Bizzarri, C. Vollono, A. Petroni, and S. Banni Adrenoleukodystrophy Endocr. Dev. 20 2011 149 160
16. A. Mahmood, G. Bibat, A.-L. Zhan, I. Izbudak, L. Farage, A. Horska, S. Mori, and S. Naidu White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations AJNR Am. J. Neuroradiol. 31 2010 295 299
17. H.Y. Zoghbi Rett syndrome: what do we know for sure? Nat. Neurosci. 12 2009 239 240
18. I. Maezawa, and L.W. Jin Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate J. Neurosci. 30 2010 5346 5356
19. D.T. Lioy, S.K. Garg, C.E. Monaghan, J. Raber, K.D. Foust, B.K. Kaspar, P.G. Hirrlinger, F. Kirchhoff, J.M. Bissonnette, N. Ballas, and G.D. Mandel A role for glia in the progression of Rett's syndrome Nature 475 2011 497 500
20. N.C. Derecki, J.C. Cronk, Z. Lu, E. Xu, S.B. Abbott, P.G. Guyenet, and J. Kipnis Wild-type microglia arrest pathology in a mouse model of Rett syndrome Nature 484 2012 105 109
21. B. De Filippis, A. Fabbri, D. Simone, R. Canese, L. Ricceri, F. Malchiodi-Albedi, G. Laviola, and C. Fiorentini Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome Neuropsychopharmacology 37 2012 1152 1163
22. H. Wang, G. Yuan, N.R. Prabhakar, M. Boswell, and D.M. Katz Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling J. Neurochem. 96 2006 694 705
23. S. Pugazhenthi, K. Phansalkar, G. Audesirk, A. West, and L. Cabell Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal Free Radic. Biol. Med. 40 2006 21 34
24. R.G. Urdinguio, L. Lopez-Serra, P. Lopez-Nieva, M. Alaminos, R. Diaz-Uriarte, A.F. Fernandez, and M. Esteller Null mice provide new neuronal targets for Rett syndrome PLoS ONE 3 2008 e3669
25. E. Cardaioli, M.T. Dotti, G. Hayek, M. Zappella, and A. Federico Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835 J. Submicrosc. Cytol. Pathol. 31 1999 301 304
26. S. Kriaucionis, A. Paterson, J. Curtis, J. Guy, N. MacLeod, and A. Bird Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome Mol. Cell. Biol. 26 2006 5033 5042
27. O. Yanes, J. Clark, D.M. Wong, G.J. Patti, A. Sanchez-Ruiz, H.P. Benton, S.A. Trauger, C. Desponts, S. Ding, and G. Siuzdak Metabolic oxidation regulates embryonic stem cell differentiation Nat. Chem. Biol. 6 2010 411 417
28. C. De Felice, C. Signorini, T. Durand, L. Ciccoli, S. Leoncini, M. D'Esposito, S. Filosa, C. Oger, A. Guy, V. Bultel-Poncé, J.M. Galano, A. Pecorelli, L. De Felice, G. Valacchi, and Y. Hayek Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil Genes Nutr. 7 2012 447 458